Drug maker Cadila Healthcare Ltd is in talks to raise around Rs 1,000 crore ($154.74 million) through a qualified institutional placement (QIP) of shares, three people aware of the development said.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
